News - Oncology, Patents

Filter

Current filters:

OncologyPatents

Popular Filters

1 to 25 of 46 results

Novartis patent settlement on Gleevec with Sun Pharma subsidiary

15-05-2014

The US unit of Swiss drug major Novartis has settled its litigation with the US subsidiary of India’s…

GenericsGleevecNovartisOncologyPatentsSun Pharmaceutical IndustriesUSA

Lilly's Alimta patent upheld through 2022

Lilly's Alimta patent upheld through 2022

01-04-2014

US pharma major Eli Lilly says that the US District Court for the Southern District of Indiana has ruled…

AlimtaEli LillyLegalNorth AmericaOncologyPatentsPharmaceuticalTeva Pharmaceutical IndustriesUSA

Roche sues Biocon and Mylan over Herceptin biosimilar; US puts pressure on India over IP

Roche sues Biocon and Mylan over Herceptin biosimilar; US puts pressure on India over IP

10-02-2014

Swiss pharma major Roche’s Indian subsidiary has sued Bangalore-based Biocon and US generics firm Mylan…

Asia-PacificBioconBiosimilarsCanmabHerceptinHertrazIndiaLegalMylan LaboratoriesOncologyPatentsPharmaceuticalRegulationRoche

Actavis confirms generic Treanda patent challenge

Actavis confirms generic Treanda patent challenge

04-02-2014

US generics drug major Actavis confirms that it has filed an Abbreviated New Drug Application with the…

ActavisCephalonGenericsNorth AmericaOncologyPatentsTeva Pharmaceutical IndustriesTreandaUSA

Ukraine government introduces compulsory licensing for pharma products

Ukraine government introduces compulsory licensing for pharma products

23-12-2013

Leading global pharmaceutical producers may suffer significant losses in Ukraine, as the country’s…

Anti-viralsAntibiotics and Infectious diseasesEastern EuropeLicensingOncologyPatentsPharmaceuticalUkraine

Another blow for Pharma, as India revokes Tykerb patent

02-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has confirmed that India's Intellectual Property Appellate…

Asia-PacificGlaxoSmithKlineLegalOncologyPatentsPharmaceuticalTykerb

Mylan enters Tarceva settlement agreement

24-07-2013

US generics firm Mylan (Nasdaq: MYL) has entered into a settlement agreement with OSI Pharmaceuticals,…

GenentechGenericsLegalMylan LaboratoriesNorth AmericaOncologyOSI PharmaceuticalsPatentsPfizerTarceva

US Court denies re-hearing of Arzerra patent case

16-07-2013

Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

Intas Pharma settles with Roche over Xeloda; Merck & Co wins injunction against Aprica

25-06-2013

Indian drugmaker Intas Pharmaceuticals and its wholly owned subsidiary Accord Healthcare have entered…

Aprica PharmaceuticalsAsia-PacificDiabetesGenericsIntas PharmaceuticalsMerck & CoNorth AmericaOncologyPatentsRocheXeloda

CML drug revenue in Japan to grow, despite global decline, says GlobalData

21-05-2013

Bucking a global trend of falling revenues, weak penetration of generic drugs and an increasing patient…

Asia-PacificBristol-Myers SquibbGleevecMarkets & MarketingNovartisOncologyPatentsPharmaceuticalSprycel

Cyclacel sells four disputed romidepsin-related patents to Celgene

05-04-2013

USA based Cyclacel Pharmaceuticals (Nasdaq: CYCC) says that it has entered into a definitive agreement…

BiotechnologyCelgeneCyclacel PharmaceuticalsLegalOncologyPatentsromidepsin

India's Supreme Court denies Novartis Glivec patent appeal

02-04-2013

In a landmark decision issued on Monday (April 1) by the Indian Supreme Court has denied Swiss drug major…

Asia-PacificGenericsGlivecLegalNovartisOncologyPatentsPharmaceutical

Indian patent appeal board upholds compulsory license on Bayer's Nexavar

05-03-2013

After much delay, the verdict into German pharmaceutical major Bayer's (BAYN: DE) appeal against the…

Asia-PacificBayerGenericsNatco PharmaNexavarOncologyPatentsPharmaceutical

Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal

12-02-2013

The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating…

Asia-PacificCiplaCipla MedproGenericsLegalMergers & AcquisitionsOncologyPatentsPfizerRest of the WorldSutent

Zhejiang Hisun Pharma pulls out of ThermoDox deal with Celsion

07-02-2013

US cancer drug developer Celsion Corp (Nasdaq: CLSN) says that Zhejiang Hisun Pharmaceutical (SSE: 600267)…

Asia-PacificCelsionLicensingOncologyPatentsPharmaceuticalThermoDoxZhejiang Hisun Pharma

Regulatory news for Hyperion's Ravicti and Seattle Genetics' Adcetris

04-02-2013

The US Food and Drug Administration on Friday approved Hyperion Therapeutics' (Nasdaq: HPTX) Ravicti…

AdcetrisBiotechnologyHyperion TherapeuticsNorth AmericaOncologyPatentsPharmaceuticalRare diseasesRavictiRegulationSeattle Genetics

Indian govt plans compulsory licences for trastuzumab, ixabepilone and dasatinib

15-01-2013

The Indian government's move to issue compulsory licences to three more patented cancer drugs has left…

Asia-PacificAvastinBristol-Myers SquibbGenericsIxempraOncologyPatentsPharmaceuticalRocheSprycel

1 to 25 of 46 results

Back to top